BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
2nd Quarter (Apr 1 - June 30)
Jul 20, 2026
Reported lobbying issue
Budget/Appropriations: HR 9495, FY2027 appropriations for DOD, specifically provisions related to medical research; HR 9260, FY2027 appropriations for HHS, specifically provisions related to medical research;
Medical/Disease Research/Clinical Labs: HR 9495, FY2027 appropriations for DOD, specifically provisions related to medical research; HR 9260, FY2027 appropriations for HHS, specifically provisions related to medical research; HR 7173, Follow the Science Act; S 4494, American Cures Act; HR 9632, Accelerating Innovation (AI) for Kids with Cancer Act; OMB Proposed Uniform Grants Regulation; Policies to enable international collaboration by NIH grantees; Policies to maintain the NIHs incremental grant funding model;
Health Issues: HR 247 / S 46, Health Care Affordability Act; S 2420, No Surprises Act Enforcement Act; HR 3521, the Clinical Trial Modernization Act; HR 5526, Biosimilar Red Tape Elimination Act; HR 5582, S 2355, the Patients Deserve Price Tags Act; HR 6248 / S 4027, Healthy Competition for Better Care Act HR 6485 / S 43, Skinny Labels, Big Savings Act; HR 6867 / S 3562, NIH Clinical Trial Integrity Act; HR 7895, the PBM Kickback Prohibition Act; HR 8908, the STOP GAMES Act; HR 9393, Lower Costs, More Transparency Act; HR 9396, the Prior Authorization Accountability Act; HR 9397, the Premium Transparency Act; HR 9661, Expedited Access to Biosimilars Act; S 1041, Affordable Prescriptions for Patients Act; S 1095, Stop STALLING Act; S 1096, Preserve Access to Affordable Generics & Biosimilars Act S 1097, Interagency Patent Coordination & Improvements Act; S 2658, Medication Affordability & Patent Integrity Act; S 3014, Ensuring Timely Access to Generics Act; S 4509, Patients Before Monopolies Act; Policies to address the expiration of the enhanced Advanced Premium Tax Credits; Policies to improve transparency in hospital and insurer costs and finances; Policies to streamline pediatric patient access to subspecialist care via telemedicine; Policies to protect patients and consumers from junk insurance, including short-term limited duration insurance; Policies related to the modernization of clinical trials; Policies related to the 2027 FDA user fee agreements; Implementation of the No Surprises Act; Policies related to oversight of insurance agents and brokers; Oversight and patient impact of the 340B program;
Medicare/Medicaid: HR 3514, Improving Seniors Timely Access to Care Act; HR 5243, a bill to increase data transparency for supplemental benefits under Medicare Advantage; HR 9392, Medicare Advantage Cost Transparency Act; S 1105, No UPCODE Act; S 1629, Same Care, Lower Cost Act; S 1936, Improving Access to Transfusion Care for Patients Act; S 4886, Medicare Cost Cap Act; CMS Interim Final Rule on Medicaid work requirements; Regulatory and legislative proposals to expand site-neutral payment in Medicare; Implementation of the Accelerating Kids Access to Care Act (HR 1509, S 752); Regulatory proposals related to most-favored-nation drug pricing;
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Reported filing-period amount: $590,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)
Registrant: ARTEMIS POLICY GROUP LLC
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Medicare/Medicaid: Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model
Health Issues: Blood and plasma safety and awareness Bleeding disorders awareness
Insurance: Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Budget/Appropriations: Funding for federal hemophilia programs in FY26 and FY27 House and Senate Labor-HHS Appropriations bills NIH FY26 and FY27 appropriations
Pharmacy: Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Medical/Disease Research/Clinical Labs: Hemophilia research, prevention, surveillance and service programs and issues; advancing care for women and girls with bleeding disorders
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
Federal Trade Commission (FTC)
Health & Human Services, Dept of (HHS)
Internal Revenue Service (IRS)
Labor, Dept of (DOL)
Treasury, Dept of
Food & Drug Administration (FDA)
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗SICKLE CELL DISEASE ASSOCIATION OF AMERICA
Registrant: ARTEMIS POLICY GROUP LLC
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Health Issues: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 1796/S. 735)
Medicare/Medicaid: Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease Implementation of H.R. 1, One Big Beautiful Bill Act Issues relating to medical listings of impairment for sickle cell disease for SSDI and SSI
Budget/Appropriations: Funding for federal sickle cell disease programs FY26 House and Senate Labor-HHS Appropriations bills FY27 House and Senate Labor-HHS Appropriations H.R. 8067, Candis King Hope for Sickle Cell Families Act
Insurance: Implementation of H.R. 1, One Big Beautiful Bill Act Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Social Security Administration (SSA)
Reported filing-period amount: $20,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Health Issues: HR 1262 / S 932, Give Kids a Chance Act; HR 3521, Clinical Trial Modernization Act; HR 2571, Self-insurance Protection Act; HR 247 / S 46, Health Care Affordability Act; HR 4317, PBM Reform Act; HR 1834, Breaking the Gridlock Act; S 2420, No Surprises Act Enforcement Act; HR 3521, the Clinical Trial Modernization Act; S 2355, the Patients Deserve Price Tags Act; Proposals related to the 2027 FDA user fee agreements; Proposals to extend enhanced Advanced Premium Tax Credits; Regulations to implement the No Surprises Act; Issues related to the cost of care, including consolidation and anti-competitive contracting
Medicare/Medicaid: HR 1509 / S 752, Accelerating Kids Access to Care Act (AKACA); S 2497, Fair Billing Act; S 1629, Same Care, Lower Cost Act; HR 7148, Consolidated Appropriations Act, specifically provisions related to Medicaid provider enrollment and a Medicare unique provider identifier requirement for hospital outpatient billing
Budget/Appropriations: HR 7148, the Consolidated Appropriations Act, specifically provisions related to medical research funding; FY2027 appropriations for HHS and DOD, specifically provisions related to medical research funding;
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE
Treasury, Dept of
Reported filing-period amount: $110,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗SUSAN G. KOMEN
Registrant: ARTEMIS POLICY GROUP LLC
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Budget/Appropriations: FY26 and FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 and FY27 appropriations for breast cancer research FY26 and FY27 appropriations for cancer prevention and control
Insurance: Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Medicare/Medicaid: Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act Submission of Information about Selected Drugs and Their Therapeutic Alternatives for Medicare Drug Price Negotiation Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Health Issues: Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Comments RE: HHS Health Sector AI RFI Comments RE: Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N, (Annual Solicitation)
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Reported filing-period amount: $40,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗THE HEMOPHILIA ALLIANCE
Registrant: ARTEMIS POLICY GROUP LLC
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Medicare/Medicaid: Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act
Insurance: Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Pharmacy: Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency
Budget/Appropriations: Funding for federal hemophilia programs at CDC and HRSA for FY26 Funding for federal hemophilia programs at CDC and HRSA for FY27
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
Federal Trade Commission (FTC)
Health & Human Services, Dept of (HHS)
Labor, Dept of (DOL)
Treasury, Dept of
Reported filing-period amount: $30,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES
Registrant: AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES
4th Quarter (Oct 1 - Dec 31)
Jan 27, 2026
Reported lobbying issue
Housing: S 934, HR 2038- American Housing and Economic Mobility Act Public Housing policies for workers, residents, units
Budget/Appropriations: S 2862- Continuing Appropriations 2026 Commerce Justice Science FY 2026 funding Interior FY 2026 funding HR 1968- Full-Year Continuing Appropriations and Extensions Act, 2025 Appropriations- Shutdown, Continuing Resolution Appropriations- HUD funding for Public Housing Operating Fund; Public Housing Capital Fund; ROSS, FSS Appropriations- IFS Budget/Funding Budget Resolution HR 1- Medicaid Cuts in Budget Reconciliation HR 5304, S 2587- Labor, HHS appropriations HR 5371- Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs Act, 2026
Clean Air and Water (quality): HR 3862- Clean Water SRF Parity Act of 2025
Defense: S 2296- National Defense Authorization Act for FY 2026
Education: HR 5658, S 2939- Child Care for Every Community
Financial Institutions/Investments/Securities: Credit Card Competition Act; Increase competition HR 3883- Consumer Protections for Financial Services investments
Government Issues: S 3039- True Shutdown Fairness Act S 3012- Shutdown Fairness Act HR 5657- Fair Pay for Federal Contractors Act of 2025 HR 5628- Pay Workers What They've Earned Act HR 5708- The Federal Employee Civil Relief Act S 3141- Securing Assurance for Federal Employees Act "SAFE Act" S 3043- Military and Federal Employee Protection Act
Agriculture: HR 6088, S 3281- Restoring Food Security for American Families and Farmers Act HR 3442, S 1095- SNAP Administrator Retention Act HR 2815, S 1420- Early Childhood Nutrition Enhancement Act HR 2811- SNAP Staffing Flexibility Act
Health Issues: HR 3492- Protect Children's Innocence Act Addressing Rising Health Care Costs S 2954- Health Care Workforce Expansion Act HR 6166- Lowering Drug Costs for American Families Act Robert F. Kennedy Jr. Nomination for HHS, oppose Dr. Mehmet Oz for CMS Administration, oppose S 46, HR 247- Health Care Affordability Act of 2025 S 750, HR 1683- Protecting America's Seniors Access to Care Act HR 2528- Association Health Care Plans Act HR 3415, S 1709- Nurse Staffing Standards for Hospital Patient Safety HR 5145- Bipartisan Premium Tax Credit Extension Act S 2824- Bill to extend ACA tax credits (2 years) HR 4849, S 2556- Protecting Health Care and Lowering Costs Act of 2025 HR 5228- HCBS Worker Protect Act HR 6703- Lower Health Care Premiums for All Americans Act S 3385- Lower Health Care Costs Act HR 3971, S 3396- Domestic Worker Bill of Rights SJ Res 82, HJ Res 25- Richardson Waiver Congressional Review Act House discharge No. 10- Jeffries ACA discharge petition
Labor Issues/Antitrust/Workplace: HR 2736, S 1352- Public Service Freedom to Negotiate Act S 852, HR 20- Richard L. Trumka Protecting the Right to Organize (PRO) Act HR 2550, S 2837- Protect America's Workforce Act S 2039- True Shutdown Fairness Act HR 5628- Pay Workers What They've Earned S 1071- National Defense Authorization Act for FY 2026 Nomination of Rosario Palmieri for DOL Nomination of Scott Mayer for NLRB Nomination of Crystal Carey for NLRB S 725- Enhancing First Response Act HR 637- 911 SAVES S 3012- Shutdown Fairness Act Collective bargaining rights of federal employees Confirmation of nominees to serve at DOL
Medicare/Medicaid: HR 498- Do No Harm in Medicaid Act funding for Disproportionate Share Hospitals Medicare sequestration
Retirement: S 3059, HR 5841- Boosting Benefits and COLAs for Seniors Act S 3255- Surviving Widow(er) Income Fair Treatment (SWIFT) Act HR 6424, S 3357- Social Security Survivor Benefits Equity Act HR 5841, S 3059- Boosting Benefits and COLAs for Seniors Act
Taxation/Internal Revenue Code: HR 6438- Redistribution of Billions by Instituting New High-Income Obligations on Overlooked Debt (ROBINHOOD) Act HR 5336- Equal Tax Act S 409, HR 995- International tax incentives for outsourcing and rates; No Tax Breaks for Outsourcing Act For the 99.5% Act; taxing estates S 2845, HR 5427- Billionaires Income Tax; taxing ultrawealthy Billionaire Minimum Income Tax; taxing ultrawealthy Raise tax rates on top earners; Tax unrealized capital gains, Tax investment income at the same rates as wages Tax the rich; Oppose new costly, inefficient tax cuts; oppose tax policies that increase tax breaks for richest taxpayers; close existing tax loopholes for wealthiest Americans; Support higher taxes on wealthy Graduated Corporate Tax Rate; taxing corporations Fair Trusts for Fiscal Responsibility Act of 2025; taxing trusts Ultramillionaires Tax Act; taxing ultrawealthy Financial transaction taxes Eliminate OBBB's tax giveaways to individuals with Incomes >$10 million; $100 million; $1 Billion S 1690, HR 3171 Medicare and Social Security Fair Share Tax S 1286, HR 2671- Tax Fairness for Workers Act; Deduction for union dues and unreimbursed workplace expenses S 1310, HR 2692- No Tax Breaks for Union Busting Act Tax Extenders, R & D Tax Credit, EITC, CTC Opportunity Zone Reform Act HR 1340- Tax on the Wealthy HR 5335- Taxing the wealthy S 2818, HR 5298- Taxing corporations with excessive CEO pay Ensure wealthy and corporations pay their fair share of taxes, enact progressive loophole closing tax laws for wealthy and corporations; raise revenues via equitable and fair tax policies ESI Health Benefits Tax Exclusion Digital Assets related tax loopholes
Transportation: S 4316- Moving Transit Forward Act HR 6635- Bus Operator Safety and Security Act
Utilities: HR 3862- Clean Water SRF Parity Act of 2025
Veterans: HR 6015- VA Care and Benefits Accountability Act HR 6014- Right to Representation for Department of Veterans Affairs Workers Act of 2025
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $700,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026
Reported lobbying issue
Health Issues: HR 1262 / S 932, Give Kids a Chance Act; HR 3521, Clinical Trial Modernization Act; HR 2571, Self-insurance Protection Act; HR 1, To provide for reconciliation pursuant to title II of H Con Res 14; HR 247 / S 46, Health Care Affordability Act; HR 4317, PBM Reform Act; HR 1834, Breaking the Gridlock Act; S 2420, No Surprises Act Enforcement Act; HR 3521, the Clinical Trial Modernization Act; Proposals to extend enhanced Advanced Premium Tax Credits
Budget/Appropriations: FY2026 appropriations for HHS, specifically provisions related to medical research funding;
Medicare/Medicaid: HR 1, To provide for reconciliation pursuant to title II of H Con Res 14; HR 1509 / S 752, Accelerating Kids Access to Care Act (AKACA); S 2497, Fair Billing Act; S 1629, Same Care, Lower Cost Act; Proposals to adopt a unique national provider identifier for individual HOPD sites
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Health & Human Services, Dept of (HHS)
Reported filing-period amount: $610,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗SICKLE CELL DISEASE ASSOCIATION OF AMERICA
Registrant: ARTEMIS POLICY GROUP LLC
4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026
Reported lobbying issue
Budget/Appropriations: Funding for federal sickle cell disease programs FY26 House and Senate Labor-HHS Appropriations bills
Medicare/Medicaid: Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease H.R. 1, One Big Beautiful Bill Act
Health Issues: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 1796/S. 735)
Insurance: H.R. 1, One Big Beautiful Bill Act Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Reported filing-period amount: $20,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)
Registrant: ARTEMIS POLICY GROUP LLC
4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026
Reported lobbying issue
Medicare/Medicaid: H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid
Health Issues: Blood and plasma safety and awareness Bleeding disorders awareness
Insurance: H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
Budget/Appropriations: Funding for federal hemophilia programs in FY26 House and Senate Labor-HHS Appropriations bills NIH FY26 appropriations
Pharmacy: Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Medical/Disease Research/Clinical Labs: Hemophilia research, prevention, surveillance and service programs and issues
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
Federal Trade Commission (FTC)
Health & Human Services, Dept of (HHS)
Internal Revenue Service (IRS)
Labor, Dept of (DOL)
Treasury, Dept of
Food & Drug Administration (FDA)
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗SUSAN G. KOMEN
Registrant: ARTEMIS POLICY GROUP LLC
4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026
Reported lobbying issue
Budget/Appropriations: FY26 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 appropriations for breast cancer research FY26 appropriations for cancer prevention and control
Insurance: Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
Medicare/Medicaid: Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act
Health Issues: Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Reported filing-period amount: $40,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗THE HEMOPHILIA ALLIANCE
Registrant: ARTEMIS POLICY GROUP LLC
4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026
Reported lobbying issue
Medicare/Medicaid: Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
Insurance: H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Pharmacy: Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation Polices related to PBMs and drug cost transparency
Budget/Appropriations: Funding for federal hemophilia programs at CDC and HRSA for FY26
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Federal Trade Commission (FTC)
Health & Human Services, Dept of (HHS)
Labor, Dept of (DOL)
Treasury, Dept of
Reported filing-period amount: $40,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗NATIONAL HEALTH COUNCIL
Registrant: NATIONAL HEALTH COUNCIL
4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026
Reported lobbying issue
Health Issues: S.1261/HR 4206 - CONNECT For Health Act of 2025 - Supported permanent extension of existing telehealth flexibilities S. 932/HR 1262 - Give Kids a Chance Act - Supported extension of Rare Pediatric Disease Priority Review Voucher Program. HR 4249/S 2257 - FY 2026 Labor/HHS/Ed Appropriations - Funding for research, programs, and services for those with chronic diseases and disabilities HR 1 - Influencing implementation of Medicaid changes included in HR 1 HR 247 - eAPTC Permanent Reauthorization - Health Care Affordability Act of 2025 - Supported extension of ACA tax credits S. 2407 - The Treat and Reduce Obesity Act - Supported coverage for anti-obesity medications S. 2903/HR 5509 - The Safe Step Act - Supported passage of common-sense utilization management exceptions S. 1717/HR 5343 - Ensuring Patient Access to Critical Breakthrough Products Act - Supported faster coverage for breakthrough devices and diagnostics HR 3521 - Clinical Trials Modernization Act - Supported codifying clinical trial diversity processes
Budget/Appropriations: HR 4249/S 2257 - FY 2026 Labor/HHS/Ed Appropriations - Funding for research, programs, and services for those with chronic diseases and disabilities
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $16,209
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES
Registrant: AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES
4th Quarter (Oct 1 - Dec 31)
Jan 16, 2026
Reported lobbying issue
Agriculture: HR 6088, S 3281- Restoring Food Security for American Families and Farmers Act HR 3442, S 1095- SNAP Administrator Retention Act HR 2815, S 1420- Early Childhood Nutrition Enhancement Act HR 2811- SNAP Staffing Flexibility Act
Budget/Appropriations: S 2862- Continuing Appropriations 2026 Commerce Justice Science FY 2026 funding Interior FY 2026 funding HR 1968- Full-Year Continuing Appropriations and Extensions Act, 2025 Appropriations- Shutdown, Continuing Resolution Appropriations- HUD funding for Public Housing Operating Fund; Public Housing Capital Fund; ROSS, FSS Appropriations- IFS Budget/Funding Budget Resolution HR 1- Medicaid Cuts in Budget Reconciliation HR 5304, S 2587- Labor, HHS appropriations HR 5371- Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs Act, 2026
Clean Air and Water (quality): HR 3862- Clean Water SRF Parity Act of 2025
Defense: S 2296- National Defense Authorization Act for FY 2026
Education: HR 5658, S 2939- Child Care for Every Community
Financial Institutions/Investments/Securities: Credit Card Competition Act; Increase competition HR 3883- Consumer Protections for Financial Services investments
Government Issues: S 3039- True Shutdown Fairness Act S 3012- Shutdown Fairness Act HR 5657- Fair Pay for Federal Contractors Act of 2025 HR 5628- Pay Workers What They've Earned Act HR 5708- The Federal Employee Civil Relief Act S 3141- Securing Assurance for Federal Employees Act "SAFE Act" S 3043- Military and Federal Employee Protection Act
Health Issues: HR 3492- Protect Children's Innocence Act Addressing Rising Health Care Costs S 2954- Health Care Workforce Expansion Act HR 6166- Lowering Drug Costs for American Families Act Robert F. Kennedy Jr. Nomination for HHS, oppose Dr. Mehmet Oz for CMS Administration, oppose S 46, HR 247- Health Care Affordability Act of 2025 S 750, HR 1683- Protecting America's Seniors Access to Care Act HR 2528- Association Health Care Plans Act HR 3415, S 1709- Nurse Staffing Standards for Hospital Patient Safety HR 5145- Bipartisan Premium Tax Credit Extension Act S 2824- Bill to extend ACA tax credits (2 years) HR 4849, S 2556- Protecting Health Care and Lowering Costs Act of 2025 HR 5228- HCBS Worker Protect Act HR 6703- Lower Health Care Premiums for All Americans Act S 3385- Lower Health Care Costs Act HR 3971, S 3396- Domestic Worker Bill of Rights SJ Res 82, HJ Res 25- Richardson Waiver Congressional Review Act House discharge No. 10- Jeffries ACA discharge petition
Housing: S 934, HR 2038- American Housing and Economic Mobility Act Public Housing policies for workers, residents, units
Labor Issues/Antitrust/Workplace: HR 2736, S 1352- Public Service Freedom to Negotiate Act S 852, HR 20- Richard L. Trumka Protecting the Right to Organize (PRO) Act HR 2550, S 2837- Protect America's Workforce Act S 2039- True Shutdown Fairness Act HR 5628- Pay Workers What They've Earned S 1071- National Defense Authorization Act for FY 2026 Nomination of Rosario Palmieri for DOL Nomination of Scott Mayer for NLRB Nomination of Crystal Carey for NLRB S 725- Enhancing First Response Act HR 637- 911 SAVES S 3012- Shutdown Fairness Act Collective bargaining rights of federal employees Confirmation of nominees to serve at DOL
Medicare/Medicaid: HR 498- Do No Harm in Medicaid Act funding for Disproportionate Share Hospitals Medicare sequestration
Retirement: S 3059, HR 5841- Boosting Benefits and COLAs for Seniors Act S 3255- Surviving Widow(er) Income Fair Treatment (SWIFT) Act HR 6424, S 3357- Social Security Survivor Benefits Equity Act HR 5841, S 3059- Boosting Benefits and COLAs for Seniors Act
Taxation/Internal Revenue Code: HR 6438- Redistribution of Billions by Instituting New High-Income Obligations on Overlooked Debt (ROBINHOOD) Act HR 5336- Equal Tax Act S 409, HR 995- International tax incentives for outsourcing and rates; No Tax Breaks for Outsourcing Act For the 99.5% Act; taxing estates S 2845, HR 5427- Billionaires Income Tax; taxing ultrawealthy Billionaire Minimum Income Tax; taxing ultrawealthy Raise tax rates on top earners; Tax unrealized capital gains, Tax investment income at the same rates as wages Tax the rich; Oppose new costly, inefficient tax cuts; oppose tax policies that increase tax breaks for richest taxpayers; close existing tax loopholes for wealthiest Americans; Support higher taxes on wealthy Graduated Corporate Tax Rate; taxing corporations Fair Trusts for Fiscal Responsibility Act of 2025; taxing trusts Ultramillionaires Tax Act; taxing ultrawealthy Financial transaction taxes Eliminate OBBB's tax giveaways to individuals with Incomes >$10 million; $100 million; $1 Billion S 1690, HR 3171 Medicare and Social Security Fair Share Tax S 1286, HR 2671- Tax Fairness for Workers Act; Deduction for union dues and unreimbursed workplace expenses S 1310, HR 2692- No Tax Breaks for Union Busting Act Tax Extenders, R & D Tax Credit, EITC, CTC Opportunity Zone Reform Act HR 1340- Tax on the Wealthy HR 5335- Taxing the wealthy S 2818, HR 5298- Taxing corporations with excessive CEO pay Ensure wealthy and corporations pay their fair share of taxes, enact progressive loophole closing tax laws for wealthy and corporations; raise revenues via equitable and fair tax policies ESI Health Benefits Tax Exclusion Digital Assets related tax loopholes
Transportation: S 4316- Moving Transit Forward Act HR 6635- Bus Operator Safety and Security Act
Utilities: HR 3862- Clean Water SRF Parity Act of 2025
Veterans: HR 6015- VA Care and Benefits Accountability Act HR 6014- Right to Representation for Department of Veterans Affairs Workers Act of 2025
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $690,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗CALIFORNIA MEDICAL ASSOCIATION INC
Registrant: CALIFORNIA MEDICAL ASSOCIATION INC.
4th Quarter (Oct 1 - Dec 31)
Jan 15, 2026
Reported lobbying issue
Medicare/Medicaid: HR 1 The One Big Beautiful Bill Act: Medicaid, the Affordable Care Act, Medicare Physician Payment, Student Loans Medicare Payment Reform, including Ruiz/Bilirakis legislation Strengthening Medicare for Patients and Providers Act of 2025 introduced Nov 20, 2025, and HR 879 Medicare Patient Access and Practice Stabilization Act (Medicare) S 1816/HR 3514 Seniors Timely Access to Care Act: Medicare Advantage Prior Authorization Reform S 1105 The No Upcode Act (Medicare Advantage) Potential Medicare Sequestration Cuts - Physician Payment Cuts HR 6160 Strengthening Medicare for Patients and Providers Act of 2025 Implementation of PL 119-21 the One Big Beautiful Bill Act. Dear Colleague Letter: Section 71115 and Section 71117 of Working Families Tax Cuts Legislation on Provider Taxes; November 14, 2025. CMS-1832-P. Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program (Published Federal Register July 16, 2025) CMS 9884-P: 2025 Marketplace Integrity and Affordability Proposed Rule CMS 2448-P: Medicaid Program; Preserving Medicaid Funding for Vulnerable Populations - Closing a Health Care-Related Tax Loophole Proposed Rule
Health Issues: S 1261/HR 4206 The Connect For Health Act of 2025 Pandemic Telehealth Waiver Extension Dear Colleague Letter HR 1585 Conrad State 30 Physician Access Reauthorization Act HR 3890/S 2439 Physician Shortage Reduction Act HR 4317 Pharmacy Benefit Manager (PBM) Reform Act of 2025 HR 4710/S 2420 No Surprises Act Enforcement Act HR 3164 Ensuring Community Access to Pharmacist Services Act CMA Press Statement regarding the Centers for Disease Control (CDC) webpage related to vaccines and autism. November 22, 2025
Education: 34 CFR; Part 685. ED-2025-OPE-0016-7221; RIN 1801-AA28: William D. Ford Federal Direct Loan Program - Public Service Loan Forgiveness Program (PSLF)
Budget/Appropriations: HR 5371 Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs and Extensions Act of 2026: Extends the Telehealth Waivers, the Teaching Health Center Primary Care GME Program, the National Health Service Corps, Community Clinics, Disproportionate Share Hospital payments; CMA urging an additional Medicare physician payment update and an extension of the Affordable Care Act premium tax credits.
Taxation/Internal Revenue Code: HR 247/S 46: Health Care Affordability Act: Extends the expiring Affordable Care Act enhanced premium Tax Credits HR 5145 Bipartisan Premium Tax Credit Extension Act: One year ACA premium tax credit extension Affordable Care Act Premium Tax Credits
Immigration: Public Charge Ground of Inadmissibility (CIS No. 2836-25; DHS USCIS- 2025-0304) December 19, 2025
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
Health & Human Services, Dept of (HHS)
Education, Dept of
Homeland Security, Dept of (DHS)
Reported filing-period amount: $101,860
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
3rd Quarter (July 1 - Sep 30)
Oct 23, 2025
Reported lobbying issue
Health Issues: HR 1262 / S 932, Give Kids a Chance Act; HR 3521, Clinical Trial Modernization Act; HR 2571, Self-insurance Protection Act; HR 1, To provide for reconciliation pursuant to title II of H Con Res 14; HR 247 / S 46, Health Care Affordability Act; HR 4317, PBM Reform Act; S 2420, No Surprises Act Enforcement Act; HR 5371, Continuing Appropriations and Extensions Act, 2026, specifically proposals to include an extension of the enhanced Advanced Premium Tax Credits
Medicare/Medicaid: HR 1, To provide for reconciliation pursuant to title II of H Con Res 14; HR 1509 / S 752, Accelerating Kids Access to Care Act (AKACA); S 2497, Fair Billing Act; S 1629, Same Care, Lower Cost Act;
Taxation/Internal Revenue Code: HR 1, To provide for reconciliation pursuant to title II of H Con Res 14, specifically provisions to expand the charitable giving tax deduction to non-itemizers; HR 801 / S 317, the Charitable Act;
Budget/Appropriations: HR 5371, Continuing Appropriations and Extensions Act, 2026, specifically provisions related to medical research funding;
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $140,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗THE HEMOPHILIA ALLIANCE
Registrant: ARTEMIS POLICY GROUP LLC
3rd Quarter (July 1 - Sep 30)
Oct 20, 2025
Reported lobbying issue
Medicare/Medicaid: Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
Insurance: H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Pharmacy: Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation 340B ACCESS Act (HR 5256) - Draft House 340B reform legislation Polices related to PBMs and drug cost transparency
Budget/Appropriations: Funding for federal hemophilia programs at CDC and HRSA for FY25 and FY26
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Federal Trade Commission (FTC)
Health & Human Services, Dept of (HHS)
Labor, Dept of (DOL)
Treasury, Dept of
Reported filing-period amount: $40,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)
Registrant: ARTEMIS POLICY GROUP LLC
3rd Quarter (July 1 - Sep 30)
Oct 20, 2025
Reported lobbying issue
Medicare/Medicaid: H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid
Health Issues: Blood and plasma safety and awareness Bleeding disorders awareness
Insurance: H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products
Budget/Appropriations: Funding for federal hemophilia programs in FY26 House and Senate Labor-HHS Appropriations bills NIH FY26 appropriations
Pharmacy: Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Medical/Disease Research/Clinical Labs: Hemophilia research, prevention, surveillance and service programs and issues
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
Federal Trade Commission (FTC)
Health & Human Services, Dept of (HHS)
Internal Revenue Service (IRS)
Labor, Dept of (DOL)
Treasury, Dept of
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗SUSAN G. KOMEN
Registrant: ARTEMIS POLICY GROUP LLC
3rd Quarter (July 1 - Sep 30)
Oct 20, 2025
Reported lobbying issue
Health Issues: Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Budget/Appropriations: Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control
Insurance: Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Medicare/Medicaid: Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act Comments RE: Proposed Rule on Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program Policies related to inclusion of new ICD-10 codes for inflammatory breast cancer and the coverage of External Breast Prostheses in Medicare
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Reported filing-period amount: $40,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES
Registrant: AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES
3rd Quarter (July 1 - Sep 30)
Oct 20, 2025
Reported lobbying issue
Agriculture: HR 3442, S 1905- SNAP Administrator Retention Act HR 2811- SNAP Staffing Flexibility Act SNAP Funding, Work Requirements, Eligibility HR 2818, S 1420- Early Childhood Nutrition Improvement Act HR 2859,S 1446- Child Care Nutrition Enhancement Act The Restoring Food Security for American Families and Farmers Act
Arts/Entertainment: Institute for Museum and Library Services
Budget/Appropriations: HR 1- One Big Beautiful Bill Act, Medicaid cuts HR 1- Reconciliation HR 5371- Continuing Appropriations and Extensions Act of 2026 S 2882- Continuing Appropriations National Science Foundation Funding FY 2025 State Department appropriations National Institutes of Health Funding FY 2026 Voice of America Appropriations FY 2026 Commerce, Science and Justice Appropriations FY 2026 Transportation and Housing Appropriations FY 2026 Financial Services and General Government Appropriations FY 2026 Interior-Environment Appropriations HR 4- Rescissions Act FY 2025 Appropriations- Continuing Resolution FY 2025 Appropriations- East-West Center Funding FY 2025-2026- HUD funding for Public Housing Operating Fund; Public Housing Capital Fund; ROSS; FSS FY 2025-2026 Appropriations- IRS Budget/Funding Budget Resolution
Clean Air and Water (quality): HR 3376, S 1730- Water Affordability, Transparency, Equity and Reliability Act
District of Columbia: HR 5125- District of Columbia Judicial Nominations Reform Act of 2025 HR 5179- District of Columbia Attorney General Appointment Reform Act of 2025 HR 5183- District of Columbia Home Rule Improvement Act
Education: HR 833, S 292- Educational Choice for Children Act, related provisions HR 5658, S 2939- Child Care for Every Community
Financial Institutions/Investments/Securities: S 2763- Keep Billionaires Out of Social Security Act
Foreign Relations: Voice of America / U.S. Agency for Global Development
Government Issues: H. Res. 369, S. Res. 198- HHS Notice and Comment on Rules PROMESA S 1585- Reduction in Force (RIF) Review Act HR 5572- Help FEDS Act HR 5628- Pay Workers What They've Earned Act HR 5657- Fair Pay for Federal Contractors Act of 2025 HR 2550- Protect America's Workforce Act
Health Issues: S 911, HR 1236- Chief Herbert Proffitt Act Medicaid- Funding, Eligibility Robert F. Kennedy Jr. Nomination for HHS/ oppose Dr. Mehmet Oz for CMS Administration/ oppose S 46, HR 247- Health Care Affordability Act of 2026 S 750, HR 1683- Protecting America's Seniors Access to Care Act HR 3415, S 1709- Nurse Staffing Standards for Hospital Patient Safety HR 5145- Bipartisan Premium Tax Credit Expansion Act S 2824- Bill to extend ACA tax credits (2 years) HR 4849, S 2556- Protecting Health Care and Lowering Costs Act of 2025 HR 5228- HCBS Worker Protection Act S 2954- Health Care Workforce Expansion Act HR 2528- Association Health Care Plans Act
Housing: S 934, HR 2038- American Housing and Economic Mobility Act Public Housing Policies and Funding
Law Enforcement/Crime/Criminal Justice: S 1595- Improve Police CARE Act HR 2502- Law Enforcement Training for Mental Health Crisis Response Act HR 4391- Bipartisan Bulletproof Vest Partnership Program Expansion Act
Labor Issues/Antitrust/Workplace: HR 2736, S 1352- Public Service Freedom to Negotiate Act HR 2550- Protect America's Workforce Act HR 3139, S 1881- Public Service Worker Protection Act S 2298, HR 4443- Asuncion Valdivia Heat Illness, Injury and Fatality Prevention Act of 2025 Minimum Wage and Overtime Collective bargaining rights of federal workers Nominee- Jonathan Berry to serve as Solicitor of Labor Nominee- Andrew Rogers to lead the Wage and Hour Administration Nominee- David Keeling to serve as Assistant Secretary of Labor for Health and Safety HR 637- 911 SAVES S 666- First Responders Wellness Act CARE for First Responders Act HR 1- OBBBA Tax cuts; Billionaire Bailout Bill S 852, HR 20- Richard L. Trumka Protecting the Right to Organize Act of 2023 S 126, HR 493- Federal Adjustment of Income Rates Act HR 492- Saving the Civil Service Act S 624, HR 491- Equal COLA Act Federal Employee Issues related to President Trump's Executive Actions: Merit staffing, Schedule F, Collective Bargaining, Official Time, Dues Deductions, Rightsizing government
Retirement: H.Res. 465- Older Americans Bill of Rights
Taxation/Internal Revenue Code: Revenues from fair taxes S 409, HR 995- International tax incentives for outsourcing and rates; No Tax Breaks for Outsourcing Act For the 99.5% Act S 2845, HR 5427- Billionaires Income Tax Billionaire Minimum Income Tax Graduated Corporate Tax Rate Fair Trusts for Fiscal Responsibility Act of 2025 Millionaires Surtax Act Financial transaction taxes Eliminate OBBB's tax giveaways to individuals with incomes greater than $10 million; $100 million; $1 billion S 1690, HR 3171- Medicare and Social Security Fair Share Tax S 1286, HR 2671- Tax Fairness for Workers Act S 1310, HR 2692- No Tax Breaks for Union Busting Act S 129- No Tax on Tips Act Tax Extenders, R & D Tax Credit, EITC, CTC Opportunity Zone Reform Act SALT ESI Health Benefits Tax Exclusion S 2818, HR 5298- Tax Excessive CEO Pay Act
Transportation: S 2520- All Aboard Act of 2025
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $750,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗SICKLE CELL DISEASE ASSOCIATION OF AMERICA
Registrant: ARTEMIS POLICY GROUP LLC
3rd Quarter (July 1 - Sep 30)
Oct 20, 2025
Reported lobbying issue
Budget/Appropriations: Funding for federal sickle cell disease programs FY25 and FY26 House and Senate Labor-HHS Appropriations bills
Insurance: H.R. 1, One Big Beautiful Bill Act Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Health Issues: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 1796/S. 735)
Medicare/Medicaid: Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721) Accelerating Kids Access to Care Act (H.R. 1509/S. 752) Medicaid eligibility and coverage for needed services for people living with sickle cell disease H.R. 1, One Big Beautiful Bill Act
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Reported filing-period amount: $20,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗CALIFORNIA MEDICAL ASSOCIATION INC
Registrant: CALIFORNIA MEDICAL ASSOCIATION INC.
3rd Quarter (July 1 - Sep 30)
Oct 17, 2025
Reported lobbying issue
Medicare/Medicaid: HR 1 The One Big Beautiful Bill Act: Medicaid, the Affordable Care Act, Medicare, Student Loans S 1816/HR 3514 Seniors Timely Access to Care Act: Medicare Advantage Prior Authorization Reform Medicare Payment Reform, including HR 879 Medicare Patient Access and Practice Stabilization Act (Medicare) Potential Medicare Sequestration Cuts - Physician Payment Cuts CMS-1832-P. Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program CMS 9884-P: 2025 Marketplace Integrity and Affordability Proposed Rule CMS 2448-P: Medicaid Program; Preserving Medicaid Funding for Vulnerable Populations - Health Care-Related Proposed Rule
Health Issues: HR 5371 Continuing Appropriations and Extensions Act of 2026: Extends the Telehealth Waivers, the Teaching Health Center Primary Care GME Program, the National Health Service Corps, Community Clinics, Disproportionate Share Hospital payments; CMA urging an additional Medicare physician payment update. Pandemic Telehealth Waiver Extension Dear Colleague Letter HR 247/S 46: Health Care Affordability Act: Extends the expiring Affordable Care Act enhanced premium Tax Credits HR 5145 Bipartisan Premium Tax Credit Extension Act: One year ACA premium tax credit extension HR 1585 Conrad State 30 Physician Access Reauthorization Act HR 3890/S 2439 Physician Shortage Reduction Act HR 4317 Pharmacy Benefit Manager (PBM) Reform Act of 2025 HR 4710/S 2420 No Surprises Act Enforcement Act CDC-2025-0454 Meeting of the Advisory Committee on Immunization Practices
Education: 34 CFR; Part 685. ED-2025-OPE-0016-7221; RIN 1801-AA28: William D. Ford Federal Direct Loan Program - Public Service Loan Forgiveness Program (PSLF)
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
Health & Human Services, Dept of (HHS)
Education, Dept of
Reported filing-period amount: $60,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
2nd Quarter (Apr 1 - June 30)
Jul 21, 2025
Reported lobbying issue
Budget/Appropriations: Annual FY26 appropriations for FDA, NIH, HHS, and DOD
Health Issues: HR 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14; HR 379, Healthcare Freedom and Choice Act; HR 483, Health Care Efficiency through Flexibility Act; HR 1509/S 752, Accelerating Kids' Access to Care Act; HR 1262/S 932, Give Kids a Chance Act; HR 2528, Association Health Plans Act; Draft legislation related to promoting investment in pediatric cancer drug development; Draft legislation related to promoting access to clinical trials; Pharmacy Benefit Manager reforms; Anti-competitive contracting reforms; CFPB medical debt regulations;
Medicare/Medicaid: HR 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14, specifically Subtitle B health provisions; Site-neutral payment reforms in Medicare;
Medical/Disease Research/Clinical Labs: Preventing Executive Branch rescissions and suspensions of NIH grants/grant funds; Education re the importance of staff roles within health agencies
Taxation/Internal Revenue Code: HR 247/S 46, the Health Care Affordability Act; HR 801/S 317, Charitable Act HR 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14, specifically provisions related to tax treatment of charitable giving
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Natl Institutes of Health (NIH)
Reported filing-period amount: $1,060,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES
Registrant: AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES
2nd Quarter (Apr 1 - June 30)
Jul 21, 2025
Reported lobbying issue
Government Issues: H Res 396, S Res 198- HHS Notice and Comment on Rules S 1585- Reduction in Force (RIF) Review Act
Agriculture: HR 3442, S 1905- SNAP Administrator Retention Act SNAP funding, work requirements, eligibility HR 5094- Emergency SNAP Funding Flexibility Act HR 1- One Big Beautiful Bill Farm Bill HR 2818, S 1420- Early Childhood Nutrition Improvement Act HR 2859, S 1446- Child Care Nutrition Enhancement Act
Arts/Entertainment: Institute for Museum and Library Services
Budget/Appropriations: HR 1- One Big Beautiful Bill Act/Budget Reconciliation/Medicaid Cuts in Budget Reconciliation FY 2026 Interior and Environment Appropriations FY 2026 Financial Services and General Government Appropriations FY 2026 Voice of America Appropriations FY 2026 Commerce, Justice and Science Appropriations FY 2026 Transportation and Housing Appropriations General, FY 2025 Appropriations- East-West Center Funding FY 2026 Appropriations- HUD funding for Public Housing Operating Fund; Public Housing Capital Fund; ROSS; FSS FY 2026 Appropriations- IRS Budget/Funding FY 2025 Appropriations- D.C. Budget/Funding Budget Resolution S 1077- District of Columbia Local Funds Act, 2025 H Con Res 14/S Con Res 7- Budget Resolution for FY 2025
Clean Air and Water (quality): HR 3376, S 1730- Water Affordability, Transparency, Equity and Reliability Act
District of Columbia: S 1077- District of Columbia Local Funds Act, 2025
Education: HR 833, S 292- Educational Choice for Children Act; Related Provisions
Foreign Relations: Voice of America / U.S. Agency for Global Development
Health Issues: HR 1410, S 739- 9/11 Responder and Survivor Health Funding Correction Act of 2024 HR 3415, S 1709- Safe Nurse Staffing HR 1- One Big Beautiful Bill Medicaid- Funding, Eligibility Robert F. Kennedy Jr. Nomination for HHS Dr. Mehmet Oz for CMS Administration S 46, HR 247- Health Care Affordability Act of 2025 S 750, HR 1683- Protecting America's Seniors Access to Care Act HR 2528- Association Health Care Plans Act
Housing: S 934, HR 2038- American Housing and Economic Mobility Act Public Housing Policies and Funding
Labor Issues/Antitrust/Workplace: HR 2736, S 1352- Public Service Freedom to Negotiate Act HR 2550- Protect America's Workforce Act HR 3139, S 1881- Public Service Worker Protection Act HR 637- 911 SAVES S 852, HR 20- Richard L Trumka Protecting the Right to Organize Act of 2023 S 126, HR 493- Federal Adjustment of Income Rates Act HR 492- Saving the Civil Service Act S 624, HR 491- Equal COLA Act Nominations- Jonathan Berry DOL Solicitor, Andrew Rodgers DOL Wage and Hour, Andrea Luca EEOC Collective bargaining rights for federal employees Federal Employee Issues related to President Trump; Trump's Executive Actions: Merit staffing, Schedule F, Collective Bargaining, Official Time, Dues Deductions, Rightsizing government
Law Enforcement/Crime/Criminal Justice: HR 3304- Providing Child Care for Police Officers Act of 2025 S 666- First Responders Wellness Act
Medicare/Medicaid: HR 1683, S 750- Protecting America's Seniors Access to Care Act Nomination- Mehmet Oz MD, Centers for Medicare and Medicaid Services
Retirement: Nomination- Frank Bisignano, Social Security Administration H Res 465- Older Americans Bill of Rights HR 2999- To amend title II of the Social Security Act to provide that not more than 10 percent of a monthly benefit may be withheld on account of overpayments
Taxation/Internal Revenue Code: Revenues from fair taxes Nomination- Bill Long, IRS Commissioner S 409, HR 995- International tax incentives for outsourcing and rates; No Tax Breaks for Outsourcing Act For the 99.5% Act Billionaires Income Tax Billionaire Minimum Income Tax Graduated Corporate Tax Rate Fair Trusts for Fiscal Responsibility Act of 2025 Millionaires Surtax Act Financial transaction taxes Eliminate One Big Beautiful Bill Act's tax giveaways to individuals with Incomes > $10 million; $100 million; $1 billion S 1690, HR 3171- Medicare and Social Security Fair Share Tax S 1286, HR 2671- Tax Fairness for Workers Act S 1310, HR 2692- No Tax Breaks for Union Busting Act S 129- No Tax on Tips Act Tax Extenders, R & D Tax Credit, EITC, CTC Opportunity Zone Reform Act SALT ESI Health Benefits Tax Exclusion
Transportation: HR 3449- Stronger Communities Through Better Transit Act
Utilities: HR 3376- Water Affordability, Transparency, Equity, and Reliability Act of 2025
Welfare: S 770- Social Security Expansion Act HR 1876- Keeping Our Field Offices Open Act HR 1877- Protecting Americans' Social Security Data Act
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $770,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
1st Quarter (Jan 1 - Mar 31)
Apr 22, 2025
Reported lobbying issue
Budget/Appropriations: HR 1968, FY2025 Full-Year Continuing Appropriations and Extensions Act; HConRes 14, Concurrent Resolution on the Budget FY2025; Potential legislation funding the Department of Defense for FY26
Health Issues: HR 379, Healthcare Freedom and Choice Act; HR 483, Health Care Efficiency through Flexibility Act; HR 1509/S 752, Accelerating Kids' Access to Care Act; HR 1262/S 932, Give Kids a Chance Act; HR 2528, Association Health Plans Act; Draft legislation related to promoting investment in pediatric cancer drug development; Draft legislation related to promoting access to clinical trials; Pharmacy Benefit Manager reforms; Anti-competitive contracting reforms; CFPB medical debt regulations;
Medicare/Medicaid: Preventing federal funding and benefit cuts to Medicaid; Site-neutral payment reforms in Medicaid;
Medical/Disease Research/Clinical Labs: Preventing Executive Branch rescissions and suspensions of NIH grants/grant funds; Education re the importance of staff roles within health agencies
Taxation/Internal Revenue Code: HR 247/S 46, the Health Care Affordability Act; HR 801/S 317, Charitable Act
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Natl Institutes of Health (NIH)
Reported filing-period amount: $130,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗Showing the 25 most recent matching disclosures.